Cookie-Einstellungen
Wir verwenden Cookies, um sicherzustellen, dass Sie auf unserer Website die bestmögliche Erfahrung machen. Weitere Informationen finden Sie in unserer Datenschutz- und Cookie-Richtlinien. ...>>>Sie können Ihre Einstellungen jederzeit ändern oder Ihre Einwilligung widerrufen, indem Sie die Cookies wie in der Richtlinie beschrieben von Ihrer Website oder Ihrem Computer löschen. Bitte akzeptieren Sie es und wählen Sie Ihre Einstellungen, indem Sie die entsprechenden Kästchen im Abschnitt "Einstellungen verwalten" unten ankreuzen. Bitte lesen Sie unsere Nutzungsbedingungen sorgfältig durch, bevor Sie einen Teil dieser Website nutzen. Show vendors
Full Title: Pathophysiological relevance of IRON deficiency and related mitochondrial dysfunction in Heart Failure with Preserved Ejection Fraction (IRON-HFpEF)
Medical condition: Heart failure with preserved ejection fraction
Full Title: An open-label, multi-centre, phase I/IIa study evaluating the safety and clinical activity of neoantigen reactive T cells in patients with metastatic or recurrent melanoma.
Medical condition: Metastatic or recurrent melanoma
Disease:
Version
SOC Term
Classification Code
Term
Level
21.1
10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
10025650
Malignant melanoma
PT
21.1
100000004865
10025651
Malignant melanoma excision
LLT
21.1
10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
10025652
Malignant melanoma in situ
PT
21.1
10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
10025670
Malignant melanoma stage III
PT
21.1
10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
10025671
Malignant melanoma stage IV
PT
21.1
10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
10053571
Melanoma
LLT
20.0
10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
10027148
Melanoma in situ
LLT
20.0
10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
10027150
Melanoma malignant
LLT
20.0
10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
10066600
Melanoma recurrent
PT
21.1
10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
10027480
Metastatic malignant melanoma
PT
20.0
10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
10027481
Metastatic melanoma
LLT
21.1
10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Full Title: ICRA (Improve Checkpoint-blockade Response in Advanced urothelial cancer), an adaptive clinical study to determine efficacy of combining weekly paclitaxel with tremelimumab +/- durvalumab (MEDI4736)
Medical condition: Metastatic urothelial carcinoma patients or patients with irresectable disease who were previously treated with chemotherapy - or are cisplatin-ineligible - and have progressed during or after trea...
Sponsor Name: Universitair Medisch Centrum Groningen
Full Title: Short-term safety, efficacy and mode of action of apremilast in mild to moderate cutaneous pemphigoid: a phase IIa open label single arm study.
Full Title: A multicenter, randomized, double-blind, placebo-controlled, crossover trial to evaluate the effects of evolocumab added to standard lipid-lowering therapy on fasting and post fat load lipids in pa...
Medical condition: Familial Dysbetalipoproteinemia